P97

Q3 Medicine
Y. Shapovalova , D. Lytkina , L. Rasskazova , A. Gudima , V. Ryabov , A. Filimoshkin , I. Kurzina , J. Kzhyshkowska
{"title":"P97","authors":"Y. Shapovalova ,&nbsp;D. Lytkina ,&nbsp;L. Rasskazova ,&nbsp;A. Gudima ,&nbsp;V. Ryabov ,&nbsp;A. Filimoshkin ,&nbsp;I. Kurzina ,&nbsp;J. Kzhyshkowska","doi":"10.1016/j.ejcsup.2015.08.088","DOIUrl":null,"url":null,"abstract":"<div><p>Orthopedic oncologic prostheses are essential in postoperative therapy and improvement of life quality of oncological patients. However, construction and composition of implants has to be improved for better biocompatibility and reduction of inflammatory responses. The materials based on polylactic acid (PLA) and hydroxyapatite (HA) have been suggested as promising solution for implant coating in order to improve reconstruction of bone defects, to reduce risk of inflammation and implant rejection.</p></div><div><h3>Objective</h3><p>To obtain the bioresorbable composites using biocompatible poly-L-lactide (PLA) with HA and to evaluate its effect on bone remodeling rate.</p></div><div><h3>Materials and methods</h3><p>After dissolution of PLA<sup>∗</sup> in chloroform the powder-like HA (<em>d</em> <!-->=<!--> <!-->20–40<!--> <!-->nm) was added under vigorous stirring (PLA: HA<!--> <!-->=<!--> <!-->75:25). The PLA/HA suspension was sonicated (40<!--> <!-->kHz) and precipitated in ethanol. Fine fibers (<em>d</em> <!-->=<!--> <!-->0.1– 0.5<!--> <!-->μm, of more than 2<!--> <!-->mm length) were formed. The PLA/HA composite fibers were air-dried; they consisted of HA nanoparticles homogeneously distributed in the PLA matrix. The composites ability to participate in bone remodeling was estimated by determination of the polymer matrix dissolution rate and by formation of the CPL on the surface of the composites.</p></div><div><h3>Results</h3><p>The degradation rate of the polymer matrix was calculated by measuring concentration of lactic acid (by HPLC method), being released from PLA macromolecules as the result of the hydrolysis in the physiologic solution (pH 7, <em>ω</em>(NaCl)<!--> <!-->=<!--> <!-->0.9%). The PLA degradation rate during the first 4 days of soaking of the substrates (<em>d</em> <!-->=<!--> <!-->10<!--> <!-->mm, <em>S</em> <!-->=<!--> <!-->190<!--> <!-->mm<sup>2</sup>, <em>m</em> <!-->=<!--> <!-->0.20<!--> <!-->±<!--> <!-->0.01<!--> <!-->g) in the solution is rather high (Clactic acid<!--> <!-->=<!--> <!-->10<!--> <!-->wt%), while on day 5 it decreases and stays constant during the rest of the time. The HA content increase in the composite results in the enhanced hydrolysis of PLA, caused both by the partial acid-base interaction between PLA and HA, and due to presence of the phase boundaries. Interesting to note that pure PLA (without HA) is hardly hydrolyzed in the physiologic solution even on the 30-th day of the experiment. Formation of calcium phosphate layer (CPL) was done in the SBF media, simulating the mineral constituents of the blood plasma at 37<!--> <!-->°C, over 28 days period. The total concentration of Ca2+ and Mg2+ ions in the SBF-solution was determined by daily trilonometry in the ammonia buffer with eriochrome black T as indicator. This investigation clearly shows that the substrates both of HA and PLA/HA promote the CLP formation on their surfaces. On day 14 of the substrates soaking in the SBF solution the increment of Ca2+, Mg2+ ions adsorbed on the HA substrate rose to the value of <em>m</em> (Ca2+<!--> <!-->+<!--> <!-->Mg2+)/VSBF<!--> <!-->=<!--> <!-->0.11<!--> <!-->mg/l, while the same value on the composite PLA/HA substrate was 0.06<!--> <!-->mg/l. Thus the rate of adsorption of Ca2+ ions on the surface of HA is higher than that on the surface of the PLA/HA substrates. It is the result of the high HA content in the material. Pure PLA does not promote adsorption of Ca2+ and Mg2+ ions from the SBF media. Thus the HA particles incorporated in the PLA matrix may cause fast the CLP formation improving the ossification in the bone reconstruction processes. Biocompatibility and anti-inflammatory activity of PLA, HA and PLA/HA composite was studied in a pilot experiment in the cell-mediated immune response of individual donors in vitro using CD14+ human monocytes. Insignificant pro-inflammatory cytokine secretion of the M1 type (TNF<em>α</em>) is observed in the presence of PLA, while HA and PLA/HA composites don’t contribute to their release. The PLA promotes the release of M2 cytokine CCL18 on day 6 of macrophage culturing suggesting potential anti-inflammatory properties of the material.</p></div><div><h3>Conclusion</h3><p>The composite PLA/HA supports active bone-like layer formation on its surface improving ossification in the bone reconstruction process. The pilot experiment suggested that PLA/HA does not cause inflammatory reactions, while PLA can potentially regulate the balance between M1/M2 reaction to suppress unnecessary inflammation.</p><p><sup>∗</sup>Mol. mass ca 60<!--> <!-->kDa, <em>prepared in the Laboratory of Catalytic Research of Tomsk State University.</em></p><p><em>This Research is supported by</em> <span><em>Tomsk State University Competitiveness Improvement Program</em></span><em>. The work was partially supported by the project</em> <span><em>Russian Foundation</em></span> <em>for Basic Research RFBR # 15-08-05496</em>_<em>a and EU IMMODGEL project, Grant No. (602694)</em>. Work was conducted with the application of the Tomsk regional common use center technical equipment acquired thanks to a grant of the Russian Ministry of the Agreement No. 14.594.21.0001 (RFMEFI59414X0001).</p></div>","PeriodicalId":11675,"journal":{"name":"Ejc Supplements","volume":"13 1","pages":"Pages 49-50"},"PeriodicalIF":0.0000,"publicationDate":"2015-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ejcsup.2015.08.088","citationCount":"4","resultStr":"{\"title\":\"P97\",\"authors\":\"Y. Shapovalova ,&nbsp;D. Lytkina ,&nbsp;L. Rasskazova ,&nbsp;A. Gudima ,&nbsp;V. Ryabov ,&nbsp;A. Filimoshkin ,&nbsp;I. Kurzina ,&nbsp;J. Kzhyshkowska\",\"doi\":\"10.1016/j.ejcsup.2015.08.088\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Orthopedic oncologic prostheses are essential in postoperative therapy and improvement of life quality of oncological patients. However, construction and composition of implants has to be improved for better biocompatibility and reduction of inflammatory responses. The materials based on polylactic acid (PLA) and hydroxyapatite (HA) have been suggested as promising solution for implant coating in order to improve reconstruction of bone defects, to reduce risk of inflammation and implant rejection.</p></div><div><h3>Objective</h3><p>To obtain the bioresorbable composites using biocompatible poly-L-lactide (PLA) with HA and to evaluate its effect on bone remodeling rate.</p></div><div><h3>Materials and methods</h3><p>After dissolution of PLA<sup>∗</sup> in chloroform the powder-like HA (<em>d</em> <!-->=<!--> <!-->20–40<!--> <!-->nm) was added under vigorous stirring (PLA: HA<!--> <!-->=<!--> <!-->75:25). The PLA/HA suspension was sonicated (40<!--> <!-->kHz) and precipitated in ethanol. Fine fibers (<em>d</em> <!-->=<!--> <!-->0.1– 0.5<!--> <!-->μm, of more than 2<!--> <!-->mm length) were formed. The PLA/HA composite fibers were air-dried; they consisted of HA nanoparticles homogeneously distributed in the PLA matrix. The composites ability to participate in bone remodeling was estimated by determination of the polymer matrix dissolution rate and by formation of the CPL on the surface of the composites.</p></div><div><h3>Results</h3><p>The degradation rate of the polymer matrix was calculated by measuring concentration of lactic acid (by HPLC method), being released from PLA macromolecules as the result of the hydrolysis in the physiologic solution (pH 7, <em>ω</em>(NaCl)<!--> <!-->=<!--> <!-->0.9%). The PLA degradation rate during the first 4 days of soaking of the substrates (<em>d</em> <!-->=<!--> <!-->10<!--> <!-->mm, <em>S</em> <!-->=<!--> <!-->190<!--> <!-->mm<sup>2</sup>, <em>m</em> <!-->=<!--> <!-->0.20<!--> <!-->±<!--> <!-->0.01<!--> <!-->g) in the solution is rather high (Clactic acid<!--> <!-->=<!--> <!-->10<!--> <!-->wt%), while on day 5 it decreases and stays constant during the rest of the time. The HA content increase in the composite results in the enhanced hydrolysis of PLA, caused both by the partial acid-base interaction between PLA and HA, and due to presence of the phase boundaries. Interesting to note that pure PLA (without HA) is hardly hydrolyzed in the physiologic solution even on the 30-th day of the experiment. Formation of calcium phosphate layer (CPL) was done in the SBF media, simulating the mineral constituents of the blood plasma at 37<!--> <!-->°C, over 28 days period. The total concentration of Ca2+ and Mg2+ ions in the SBF-solution was determined by daily trilonometry in the ammonia buffer with eriochrome black T as indicator. This investigation clearly shows that the substrates both of HA and PLA/HA promote the CLP formation on their surfaces. On day 14 of the substrates soaking in the SBF solution the increment of Ca2+, Mg2+ ions adsorbed on the HA substrate rose to the value of <em>m</em> (Ca2+<!--> <!-->+<!--> <!-->Mg2+)/VSBF<!--> <!-->=<!--> <!-->0.11<!--> <!-->mg/l, while the same value on the composite PLA/HA substrate was 0.06<!--> <!-->mg/l. Thus the rate of adsorption of Ca2+ ions on the surface of HA is higher than that on the surface of the PLA/HA substrates. It is the result of the high HA content in the material. Pure PLA does not promote adsorption of Ca2+ and Mg2+ ions from the SBF media. Thus the HA particles incorporated in the PLA matrix may cause fast the CLP formation improving the ossification in the bone reconstruction processes. Biocompatibility and anti-inflammatory activity of PLA, HA and PLA/HA composite was studied in a pilot experiment in the cell-mediated immune response of individual donors in vitro using CD14+ human monocytes. Insignificant pro-inflammatory cytokine secretion of the M1 type (TNF<em>α</em>) is observed in the presence of PLA, while HA and PLA/HA composites don’t contribute to their release. The PLA promotes the release of M2 cytokine CCL18 on day 6 of macrophage culturing suggesting potential anti-inflammatory properties of the material.</p></div><div><h3>Conclusion</h3><p>The composite PLA/HA supports active bone-like layer formation on its surface improving ossification in the bone reconstruction process. The pilot experiment suggested that PLA/HA does not cause inflammatory reactions, while PLA can potentially regulate the balance between M1/M2 reaction to suppress unnecessary inflammation.</p><p><sup>∗</sup>Mol. mass ca 60<!--> <!-->kDa, <em>prepared in the Laboratory of Catalytic Research of Tomsk State University.</em></p><p><em>This Research is supported by</em> <span><em>Tomsk State University Competitiveness Improvement Program</em></span><em>. The work was partially supported by the project</em> <span><em>Russian Foundation</em></span> <em>for Basic Research RFBR # 15-08-05496</em>_<em>a and EU IMMODGEL project, Grant No. (602694)</em>. Work was conducted with the application of the Tomsk regional common use center technical equipment acquired thanks to a grant of the Russian Ministry of the Agreement No. 14.594.21.0001 (RFMEFI59414X0001).</p></div>\",\"PeriodicalId\":11675,\"journal\":{\"name\":\"Ejc Supplements\",\"volume\":\"13 1\",\"pages\":\"Pages 49-50\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.ejcsup.2015.08.088\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ejc Supplements\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1359634915000890\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ejc Supplements","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1359634915000890","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 4

摘要

骨科肿瘤假体是肿瘤患者术后治疗和提高生活质量的重要手段。然而,为了更好的生物相容性和减少炎症反应,植入物的结构和组成必须得到改进。聚乳酸(PLA)和羟基磷灰石(HA)是一种很有前途的种植体涂层材料,可以改善骨缺损的重建,降低炎症和种植体排斥反应的风险。目的制备生物相容性聚l -丙交酯(PLA)与透明质酸(HA)复合材料,并评价其对骨重塑率的影响。材料与方法PLA *在氯仿中溶解后,在剧烈搅拌下加入粉末状HA (d = 20 ~ 40 nm) (PLA: HA = 75:25)。PLA/HA悬浮液超声(40 kHz),在乙醇中沉淀。形成细纤维(d = 0.1 ~ 0.5 μm,长度大于2mm)。将PLA/HA复合纤维风干;它们由均匀分布在聚乳酸基质中的HA纳米颗粒组成。通过测定聚合物基质的溶解速率和复合材料表面CPL的形成来估计复合材料参与骨重塑的能力。结果通过测定聚乳酸大分子在生理溶液(pH = 7, ω(NaCl) = 0.9%)中水解后释放的乳酸浓度(HPLC法)计算聚合物基体的降解率。在底物浸泡的前4天(d = 10 mm, S = 190 mm2, m = 0.20±0.01 g)溶液中(乳酸= 10 wt%), PLA的降解率相当高,而在第5天,PLA的降解率下降,其余时间保持不变。复合材料中HA含量的增加导致PLA的水解增强,这是由于PLA和HA之间的部分酸碱相互作用以及相边界的存在造成的。有趣的是,即使在实验的第30天,纯PLA(不含HA)在生理溶液中也几乎没有水解。在模拟血浆矿物质成分的SBF培养基中,在37°C下,28天内形成磷酸钙层(CPL)。以染色黑T为指示剂,在氨水缓冲液中采用每日三次滴定法测定sbf溶液中Ca2+和Mg2+离子的总浓度。本研究清楚地表明,透明质酸和聚乳酸/透明质酸的底物都促进了其表面上CLP的形成。在SBF溶液中浸泡的第14天,HA底物上吸附的Ca2+、Mg2+离子增量达到m (Ca2+ + Mg2+)/VSBF = 0.11 mg/l,而PLA/HA复合底物上吸附的Ca2+、Mg2+离子增量为0.06 mg/l。因此,钙离子在HA表面的吸附速率高于PLA/HA底物表面的吸附速率。这是材料中HA含量高的结果。纯PLA不促进Ca2+和Mg2+离子从SBF介质的吸附。因此,掺入PLA基质中的HA颗粒可能会加速CLP的形成,从而改善骨重建过程中的骨化。利用CD14+人单核细胞,研究了聚乳酸、透明质酸和聚乳酸/透明质酸复合物在体外个体供体细胞免疫应答中的生物相容性和抗炎活性。PLA存在时,M1型促炎细胞因子(TNFα)分泌不明显,HA和PLA/HA复合物不促进其释放。PLA在巨噬细胞培养第6天促进M2细胞因子CCL18的释放,提示该材料具有潜在的抗炎特性。结论PLA/HA复合材料在其表面支持活性骨样层的形成,促进骨重建过程中的骨化。预实验表明PLA/HA不会引起炎症反应,而PLA可以调节M1/M2反应的平衡,抑制不必要的炎症。质量约60 kDa,在托木斯克国立大学催化研究实验室制备。本研究得到托木斯克国立大学竞争力提升计划的支持。本研究得到俄罗斯基础研究基金会RFBR # 15-08-05496_a项目和EU IMMODGEL项目的部分资助。(602694)。工作是利用托木斯克地区通用中心的技术设备进行的,这些设备是由俄罗斯政府根据第14.594.21.0001号协议(RFMEFI59414X0001)授予的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
P97

Orthopedic oncologic prostheses are essential in postoperative therapy and improvement of life quality of oncological patients. However, construction and composition of implants has to be improved for better biocompatibility and reduction of inflammatory responses. The materials based on polylactic acid (PLA) and hydroxyapatite (HA) have been suggested as promising solution for implant coating in order to improve reconstruction of bone defects, to reduce risk of inflammation and implant rejection.

Objective

To obtain the bioresorbable composites using biocompatible poly-L-lactide (PLA) with HA and to evaluate its effect on bone remodeling rate.

Materials and methods

After dissolution of PLA in chloroform the powder-like HA (d = 20–40 nm) was added under vigorous stirring (PLA: HA = 75:25). The PLA/HA suspension was sonicated (40 kHz) and precipitated in ethanol. Fine fibers (d = 0.1– 0.5 μm, of more than 2 mm length) were formed. The PLA/HA composite fibers were air-dried; they consisted of HA nanoparticles homogeneously distributed in the PLA matrix. The composites ability to participate in bone remodeling was estimated by determination of the polymer matrix dissolution rate and by formation of the CPL on the surface of the composites.

Results

The degradation rate of the polymer matrix was calculated by measuring concentration of lactic acid (by HPLC method), being released from PLA macromolecules as the result of the hydrolysis in the physiologic solution (pH 7, ω(NaCl) = 0.9%). The PLA degradation rate during the first 4 days of soaking of the substrates (d = 10 mm, S = 190 mm2, m = 0.20 ± 0.01 g) in the solution is rather high (Clactic acid = 10 wt%), while on day 5 it decreases and stays constant during the rest of the time. The HA content increase in the composite results in the enhanced hydrolysis of PLA, caused both by the partial acid-base interaction between PLA and HA, and due to presence of the phase boundaries. Interesting to note that pure PLA (without HA) is hardly hydrolyzed in the physiologic solution even on the 30-th day of the experiment. Formation of calcium phosphate layer (CPL) was done in the SBF media, simulating the mineral constituents of the blood plasma at 37 °C, over 28 days period. The total concentration of Ca2+ and Mg2+ ions in the SBF-solution was determined by daily trilonometry in the ammonia buffer with eriochrome black T as indicator. This investigation clearly shows that the substrates both of HA and PLA/HA promote the CLP formation on their surfaces. On day 14 of the substrates soaking in the SBF solution the increment of Ca2+, Mg2+ ions adsorbed on the HA substrate rose to the value of m (Ca2+ + Mg2+)/VSBF = 0.11 mg/l, while the same value on the composite PLA/HA substrate was 0.06 mg/l. Thus the rate of adsorption of Ca2+ ions on the surface of HA is higher than that on the surface of the PLA/HA substrates. It is the result of the high HA content in the material. Pure PLA does not promote adsorption of Ca2+ and Mg2+ ions from the SBF media. Thus the HA particles incorporated in the PLA matrix may cause fast the CLP formation improving the ossification in the bone reconstruction processes. Biocompatibility and anti-inflammatory activity of PLA, HA and PLA/HA composite was studied in a pilot experiment in the cell-mediated immune response of individual donors in vitro using CD14+ human monocytes. Insignificant pro-inflammatory cytokine secretion of the M1 type (TNFα) is observed in the presence of PLA, while HA and PLA/HA composites don’t contribute to their release. The PLA promotes the release of M2 cytokine CCL18 on day 6 of macrophage culturing suggesting potential anti-inflammatory properties of the material.

Conclusion

The composite PLA/HA supports active bone-like layer formation on its surface improving ossification in the bone reconstruction process. The pilot experiment suggested that PLA/HA does not cause inflammatory reactions, while PLA can potentially regulate the balance between M1/M2 reaction to suppress unnecessary inflammation.

Mol. mass ca 60 kDa, prepared in the Laboratory of Catalytic Research of Tomsk State University.

This Research is supported by Tomsk State University Competitiveness Improvement Program. The work was partially supported by the project Russian Foundation for Basic Research RFBR # 15-08-05496_a and EU IMMODGEL project, Grant No. (602694). Work was conducted with the application of the Tomsk regional common use center technical equipment acquired thanks to a grant of the Russian Ministry of the Agreement No. 14.594.21.0001 (RFMEFI59414X0001).

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Ejc Supplements
Ejc Supplements 医学-肿瘤学
自引率
0.00%
发文量
0
审稿时长
3.7 months
期刊介绍: EJC Supplements is an open access companion journal to the European Journal of Cancer. As an open access journal, all published articles are subject to an Article Publication Fee. Immediately upon publication, all articles in EJC Supplements are made openly available through the journal''s websites. EJC Supplements will consider for publication the proceedings of scientific symposia, commissioned thematic issues, and collections of invited articles on preclinical and basic cancer research, translational oncology, clinical oncology and cancer epidemiology and prevention. Authors considering the publication of a supplement in EJC Supplements are requested to contact the Editorial Office of the EJC to discuss their proposal with the Editor-in-Chief. EJC Supplements is an official journal of the European Organisation for Research and Treatment of Cancer (EORTC), the European CanCer Organisation (ECCO) and the European Society of Mastology (EUSOMA).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信